These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 11191694

  • 21. Atypical neuroleptic malignant syndrome associated with risperidone treatment in two adolescents.
    Zalsman G, Lewis R, Konas S, Loebstein O, Goldberg P, Burguillo F, Nahshoni E, Munitz H.
    Int J Adolesc Med Health; 2004; 16(2):179-82. PubMed ID: 15266995
    [Abstract] [Full Text] [Related]

  • 22. [Neuroleptic malignant syndrome in users of risperidone].
    van Bemmel T, Westendorp RG.
    Ned Tijdschr Geneeskd; 2005 Mar 12; 149(11):608; author reply 608. PubMed ID: 15799646
    [No Abstract] [Full Text] [Related]

  • 23. Potentiating effect of fluphenazine decanoate and risperidone on development of neuroleptic malignant syndrome.
    Liu PY, Wu PC, Chen CY, Chen YC.
    Gen Hosp Psychiatry; 2011 Mar 12; 33(1):84.e5-7. PubMed ID: 21353143
    [Abstract] [Full Text] [Related]

  • 24. [Neuroleptic malignant syndrome : Rare cause of fever of unknown origin].
    Chackupurakal R, Wild U, Kamm M, Wappler F, Reske D, Sakka SG.
    Anaesthesist; 2015 Jul 12; 64(7):527-31. PubMed ID: 26122200
    [Abstract] [Full Text] [Related]

  • 25. Neuroleptic malignant syndrome with delayed onset of fever following risperidone administration.
    Norris B, Angeles V, Eisenstein R, Seale JP.
    Ann Pharmacother; 2006 Dec 12; 40(12):2260-4. PubMed ID: 17119106
    [Abstract] [Full Text] [Related]

  • 26. Neuroleptic malignant syndrome associated with atypical antipsychotics in pediatric patients: a review of published cases.
    Croarkin PE, Emslie GJ, Mayes TL.
    J Clin Psychiatry; 2008 Jul 12; 69(7):1157-65. PubMed ID: 18572981
    [Abstract] [Full Text] [Related]

  • 27. Patients with neuroleptic malignant syndrome histories: what happens when they are rehospitalized?
    Gelenberg AJ, Bellinghausen B, Wojcik JD, Falk WE, Farhadi AM.
    J Clin Psychiatry; 1989 May 12; 50(5):178-80. PubMed ID: 2565897
    [Abstract] [Full Text] [Related]

  • 28. Neuroleptic malignant syndrome associated with risperidone in a male with early-onset schizophrenia.
    Mané A, Baeza I, Morer A, Lázaro ML, Bernardo M.
    J Child Adolesc Psychopharmacol; 2005 Dec 12; 15(6):844-5. PubMed ID: 16379503
    [No Abstract] [Full Text] [Related]

  • 29. A novel clinical observation in neuroleptic malignant-like syndrome: first demonstration of early progression of hydrocephalus.
    Kazdal H, Kanat A, Sen A, Kirbas S, Ardic G, Tufekci A, Ersoz T.
    J Clin Psychopharmacol; 2015 Apr 12; 35(2):211-2. PubMed ID: 25679124
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Catatonia and neuroleptic malignant syndrome: two disorders on a same spectrum? Three case reports].
    Luchini F, Lattanzi L, Bartolommei N, Cosentino L, Casamassima F, Litta A, Mauri M, Cassano GB.
    Riv Psichiatr; 2012 Apr 12; 47(2):178-85. PubMed ID: 22622253
    [Abstract] [Full Text] [Related]

  • 32. High-dose vitamin E plus vitamin B6 treatment of risperidone-related neuroleptic malignant syndrome.
    Dursun SM, Oluboka OJ, Devarajan S, Kutcher SP.
    J Psychopharmacol; 1998 Apr 12; 12(2):220-1. PubMed ID: 9694035
    [Abstract] [Full Text] [Related]

  • 33. Neuroleptic malignant syndrome caused by combination of risperidone and lithium in a patient with multiple medical comorbidities.
    Kosehasanogullari SG, Akdede B, Akvardar Y, Akan M, Tunca Z.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun 30; 31(5):1147-8. PubMed ID: 17513032
    [No Abstract] [Full Text] [Related]

  • 34. Office-based General Anesthesia for a Patient With a History of Neuroleptic Malignant Syndrome.
    Messieha ZS.
    Anesth Prog; 2023 Mar 01; 70(1):20-24. PubMed ID: 36995955
    [Abstract] [Full Text] [Related]

  • 35. Risperidone, neuroleptic malignant syndrome and probable dementia with Lewy bodies.
    Sechi G, Agnetti V, Masuri R, Deiana GA, Pugliatti M, Paulus KS, Rosati G.
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Aug 01; 24(6):1043-51. PubMed ID: 11041543
    [Abstract] [Full Text] [Related]

  • 36. A case report of neuroleptic malignant syndrome without fever in a patient given aripiprazole.
    Rodriguez OP, Dowell MS.
    J Okla State Med Assoc; 2006 Aug 01; 99(7):435-8. PubMed ID: 17017330
    [Abstract] [Full Text] [Related]

  • 37. Neuroleptic malignant syndrome associated with risperidone and olanzapine in first-episode schizophrenia.
    Aboraya A, Schumacher J, Abdalla E, LePage J, McGhee M, Butcher D, Griffin H, Shahda M.
    W V Med J; 2002 Aug 01; 98(2):63-5. PubMed ID: 12048741
    [Abstract] [Full Text] [Related]

  • 38. Olanzapine-induced neuroleptic malignant syndrome in a patient with paranoid schizophrenia.
    Srivastava A, Borkar HA, Chandak S.
    Psychiatry Clin Neurosci; 2009 Feb 01; 63(1):119-21. PubMed ID: 19067992
    [Abstract] [Full Text] [Related]

  • 39. [Neuroleptic malignant syndrome caused by olanzapine, risperidone and haloperidol].
    Marloth PV, Ladefoged MR, Boesen MS.
    Ugeskr Laeger; 2022 Nov 07; 184(45):. PubMed ID: 36345898
    [Abstract] [Full Text] [Related]

  • 40. Recurrence of neuroleptic malignant syndrome.
    Susman VL, Addonizio G.
    J Nerv Ment Dis; 1988 Apr 07; 176(4):234-41. PubMed ID: 2895164
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.